Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.

ClinicalTrials.gov ID: NCT00362232

Public ClinicalTrials.gov record NCT00362232. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 25, 2026, 2:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

RECORD 4 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE; a Controlled, Double-blind, Randomized Study of BAY59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess if 10 mg BAY59-7939, taken once daily as a tablet, is safe and prevents blood clot which may form after a knee replacement operation.

Study identification

NCT ID: NCT00362232
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Bayer; Industry
Enrollment: 3,148 participants

Conditions and interventions

Conditions

Venous Thromboembolism

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 2006 (Type not available)
Primary completion: Jan 2007 (Actual)
Completion: Jan 2008 (Actual)
Last update posted: Nov 4, 2014

2006 – 2008

United States locations

U.S. sites: 40
U.S. states: 18
U.S. cities: 39

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	35209	—
Not listed	Tuscaloosa	Alabama	35406	—
Not listed	Phoenix	Arizona	85023	—
Not listed	Little Rock	Arkansas	72205	—
Not listed	Bakersfield	California	93309	—
Not listed	Encinitas	California	92024	—
Not listed	Fountain Valley	California	92708	—
Not listed	La Jolla	California	92037	—
Not listed	Torrance	California	90502-2004	—
Not listed	Yuba City	California	95991	—
Not listed	Centennial	Colorado	80112	—
Not listed	Denver	Colorado	80230	—
Not listed	Englewood	Colorado	80110	—
Not listed	Boynton Beach	Florida	33472-2952	—
Not listed	Clearwater	Florida	33756	—
Not listed	DeLand	Florida	32720	—
Not listed	Hollywood	Florida	33021	—
Not listed	Jacksonville	Florida	32216	—
Not listed	Pensacola	Florida	32501	—
Not listed	Pinellas Park	Florida	33781	—
Not listed	Decatur	Georgia	30033	—
Not listed	Boise	Idaho	83702	—
Not listed	Meridian	Idaho	83642	—
Not listed	Towson	Maryland	21204	—
Not listed	Missoula	Montana	59802	—
Not listed	Teaneck	New Jersey	07666	—
Not listed	Greensboro	North Carolina	27401	—
Not listed	Cincinnati	Ohio	45242	—
Not listed	Oklahoma City	Oklahoma	73162	—
Not listed	Johnstown	Pennsylvania	15901	—
Not listed	State College	Pennsylvania	16801	—
Not listed	Charleston	South Carolina	29414	—
Not listed	Dallas	Texas	75231	—
Not listed	Grapevine	Texas	76051	—
Not listed	Houston	Texas	77030	—
Not listed	Lubbock	Texas	79410	—
Not listed	Plano	Texas	75093	—
Not listed	San Antonio	Texas	78205	—
Not listed	San Antonio	Texas	78233	—
Not listed	Spokane	Washington	99218	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 84 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00362232, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 4, 2014 · Synced Oct 25, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00362232 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →